Multicenter closed-loop/hybrid meal bolus insulin delivery with type 1 diabetes

Diabetes Technology and Therapeutics

Volumn 16, Issue 10, 2014, Pages 623-632

  Chase, H Peter ^a   Doyle, Francis J ^b   Zisser, Howard ^c   Renard, Eric ^d   Nimri, Revital ^e   Cobelli, Claudio ^f   Buckingham, Bruce A ^g   Maahs, David M ^a   Anderson, Stacey ^h   Magni, Lalo ^f   Lum, John ^d   Calhoun, Peter ^d   Kollman, Craig ^d   Beck, Roy W ⁱ   Jovanovic, Lois ^c   Wollitzer, Alison ^c   Bevier, Wendy ^c   Dassau, Eyal ^c   Castorino, Kristin ^c   Markova, Kateryna ^c   Wiley, Jacqueline ^c   Beveridge, Erin ^c   Santibanez, Nicolas ^c   Sales, Alexandra ^c   Bradley, Maia ^c   Castorino, Adam ^c   Kovatchev, Boris ^h   Demartini, Susan ^h   Brown, Sue ^h   Clarke, William ^h   Breton, Marc ^h   Patek, Stephen ^h   Keith Hynes, Patrick ^h   Hughes Karvetski, Colleen ^h   McElwee, Molly ^h   Oliveri, Mary ^h   Wakeman, Christian ^h   Farret, Anne ⁱ   Pelletier, Marie Josee ⁱ   Chevassus, Hugues ⁱ   Place, Jerome ⁱ   Phillip, Moshe ^c   Atlas, Eran ^c   Oron, Tal ^c   Farfel, Alon ^c   Demol, Sharon ^c   Mel, Eran ^c   Ben Ari, Tal ^c   Gilon, Michael ^c   Parnes, Ayele ^c   Muller, Ido ^c   Miller, Shahar ^c   Hamou, Alona ^c   Hermon, Orna ^c   Shiovitch Mantzuri, Galit ^c   Fayman, Galia ^c   Man, Chiara Dalla ^f   Avogaro, Angelo ^f   Bruttomesso, Daniela ^f   Maran, Alberto ^f   Schiavon, Michele ^f   Del Favero, Simone ^f   Vistenin, Roberto ^f   Scotton, Rachele ^f   Filippi, Alessio ^f   Toffanin, Chiara ^f   De Nicolao, Giuseppe ^f   Mancini, Simone ^f   Raimondo, Davide Martino ^f   Wilson, Darrell M ^g   Benassi, Kari ^g   Clinton, Paula ^g   Harris, Breanne P ^g   Shanmugham, Satya ^g   Caswell, Kimberly ^g   Slover, Robert ^a   Sullivan, Sally ^a   Messer, Laurel ^a   Gage, Victoria ^a   Realsen, Jaime ^a   Westfall, Emily ^a   Goettle, Hannah ^a   Sibayan, Judy ⁱ   Njeru, Nelly M ⁱ   Sauer, Werner ⁱ   Pickup, John C ^j   Hirsch, Irl ^j   Wolpert, Howard ^j   more..

^a UNIVERSITY OF COLORADO DENVER   (United States)

^b University of California   (United States)

^c SANSUM DIABETES RESEARCH INSTITUTE   (United States)

^d MONTPELLIER UNIVERSITY HOSPITAL   (France)

^e TEL AVIV UNIVERSITY   (Israel)

^f UNIVERSITY OF PADOVA   (Italy)

^g STANFORD UNIVERSITY   (United States)

^h UNIVERSITY OF VIRGINIA   (United States)

ⁱ JAEB CENTER FOR HEALTH RESEARCH   (United States)

^j Stanford University ^*

more..

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; GLUCOSE; INSULIN; ANTIDIABETIC AGENT; CARBOHYDRATE DIET; GLUCOSE BLOOD LEVEL;

ADULT; AGED; ARTICLE; ARTIFICIAL PANCREAS; BLOOD GLUCOSE METER; BLOOD GLUCOSE MONITORING; BODY WEIGHT; BOLUS INJECTION; CARBOHYDRATE INTAKE; CHILD; CLINICAL ARTICLE; CLOSED LOOP HYBRID MEAL BOLUS INSULIN DELIVERY; CONTINUOUS INFUSION; DIABETIC PATIENT; DRUG DELIVERY SYSTEM; GLUCOSE BLOOD LEVEL; GLUCOSE SENSOR; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN PUMP; MULTICENTER STUDY; POSTPRANDIAL STATE; ADOLESCENT; ALGORITHM; BLOOD; CARBOHYDRATE DIET; CLINICAL TRIAL; DIABETES MELLITUS, TYPE 1; EVALUATION STUDY; FEMALE; MALE; MEAL; METABOLISM; MIDDLE AGED; PATIENT COMPLIANCE; UNITED STATES;

ADOLESCENT; ADULT; ALGORITHMS; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CHILD; DIABETES MELLITUS, TYPE 1; DIETARY CARBOHYDRATES; FEMALE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN INFUSION SYSTEMS; MALE; MEALS; MIDDLE AGED; PANCREAS, ARTIFICIAL; PATIENT COMPLIANCE; POSTPRANDIAL PERIOD; UNITED STATES;

EID: 84907531638     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2014.0050     Document Type: Article

References (34)

1. Standards of medical care in diabetes-2013. Diabetes Care 2013;36(Suppl 1):S11-S66.
2. Cobry E, McFann K, Messer L, Gage V, VanderWel B, Horton L, Chase HP: Timing of meal insulin boluses to achieve optimal postprandial glycemic control in patients with type 1 diabetes. Diabetes Technol Ther 2010;12:173-177.
3. Luijf YM, van Bon AC, Hoekstra JB, Devries JH: Premeal injection of rapid-acting insulin reduces postprandial glycemic excursions in type 1 diabetes. Diabetes Care 2010; 33:2152-2155.
4. Castle JR, Engle JM, El Youssef J, Massoud RG, Yuen KC, Kagan R, Ward WK: Novel use of glucagon in a closedloop system for prevention of hypoglycemia in type 1 diabetes. Diabetes Care 2010;33:1282-1287.
5. Luijf YM, DeVries JH, Zwinderman K, Leelarathna L, Nodale M, Caldwell K, Kumareswaran K, Elleri D, Allen JM, Wilinska ME, Evans ML, Hovorka R, Doll W, Ellmerer M, Mader JK, Renard E, Place J, Farret A, Cobelli C, Del Favero S, Dalla Man C, Avogaro A, Bruttomesso D, Filippi A, Scotton R, Magni L, Lanzola G, Di Palma F, Soru P, Toffanin C, De Nicolao G, Arnolds S, Benesch C, Heinemann L: Day and night closed-loop control in adults with type 1 diabetes: a comparison of two closed-loop algorithms driving continuous subcutaneous insulin infusion versus patient self-management. Diabetes Care 2013;36: 3882-3887.
6. Russell SJ, El-Khatib FH, Nathan DM, Magyar KL, Jiang J, Damiano ER: Blood glucose control in type 1 diabetes with a bihormonal bionic endocrine pancreas. Diabetes Care 2012;35:2148-2155.
7. Weinzimer SA, Steil GM, Swan KL, Dziura J, Kurtz N, Tamborlane WV: Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care 2008;31:934-939.
8. El-Khatib FH, Russell SJ, Nathan DM, Sutherlin RG, Damiano ER: A bihormonal closed-loop artificial pancreas for type 1 diabetes. Sci Transl Med 2010;2:27ra27.
9. Zisser H, Jovanovic L, Doyle F 3rd, Ospina P, Owens C: Run-to-run control of meal-related insulin dosing. Diabetes Technol Ther 2005;7:48-57.
10. Rutledge KS, Chase HP, Klingensmith GJ, Walravens PA, Slover RH, Garg SK: Effectiveness of postprandial Humalog in toddlers with diabetes. Pediatrics 1997;100:968-972.
11. Burdick J, Chase HP, Slover RH, Knievel K, Scrimgeour L, Maniatis AK, Klingensmith GJ: Missed insulin meal boluses and elevated hemoglobin A1c levels in children receiving insulin pump therapy. Pediatrics 2004;113:e221-e224.
12. Olinder AL, Kernell A, Smide B: Missed bolus doses: devastating for metabolic control in CSII-treated adolescents with type 1 diabetes. Pediatr Diabetes 2009;10:142-148.
13. Vanderwel BW, Messer LH, Horton LA, McNair B, Cobry EC, McFann KK, Chase HP: Missed insulin boluses for snacks in youth with type 1 diabetes. Diabetes Care 2010; 33:507-508.
14. Kramer CK, Borgono CA, Van Nostrand P, Retnakaran R, Zinman B: Glucagon response to oral glucose challenge in type 1 diabetes: lack of impact of euglycemia. Diabetes Care 2014;37:1076-1082.
15. Rosenstock J, Park G, Zimmerman J; U.S. Insulin Glargine (HOE 901) Type 1 Diabetes Investigator Group: Basal insulin glargine (HOE 901) versus NPH insulin in patients with type 1 diabetes on multiple daily insulin regimens. Diabetes Care 2000;23:1137-1142.
16. Breton M, Farret A, Bruttomesso D, Anderson S, Magni L, Patek S, Dalla Man C, Place J, Demartini S, Del Favero S, Toffanin C, Hughes-Karvetski C, Dassau E, Zisser H, Doyle FJ 3rd, De Nicolao G, Avogaro A, Cobelli C, Renard E, Kovatchev B: Fully integrated artificial pancreas in type 1 diabetes: modular closed-loop glucose control maintains near normoglycemia. Diabetes 2012;61:2230-2237.
17. Cobelli C, Renard E, Kovatchev B: Artificial pancreas: past, present, future. Diabetes 2011;60:2672-2682.
18. Hughes CS, Patek SD, Breton MD, Kovatchev BP: Hypoglycemia prevention via pump attenuation and red-yellowgreen "traffic" lights using continuous glucose monitoring and insulin pump data. J Diabetes Sci Technol 2010;4:1146-1155.
19. Kovatchev B, Cobelli C, Renard E, Anderson S, Breton M, Patek S, Clarke W, Bruttomesso D, Maran A, Costa S, Avogaro A, Dalla Man C, Facchinetti A, Magni L, De Nicolao G, Place J, Farret A: Multinational study of subcutaneous model-predictive closed-loop control in type 1 diabetes mellitus: summary of the results. J Diabetes Sci Technol 2010;4:1374-1381.
20. Kovatchev B, Patek S, Dassau E, Doyle FJ III, Magni L, De Nicolao G, Cobelli C; Juvenile Diabetes Research Foundation Artificial Pancreas Consortium: Control to range for diabetes: functionality and modular architecture. J Diabetes Sci Technol 2009;3:1058-1065.
21. Magni L, Raimondo DM, Bossi L, Dalla Man C, De Nicolao G, Kovatchev B, Cobelli C: Model predictive control of type 1 diabetes: an in silico trial. J Diabetes Sci Technol 2007;1:804-812.
22. Patek SD, Magni L, Dassau E, Karvetski C, Toffanin C, De Nicolao G, Del Favero S, Breton M, Man CD, Renard E, Zisser H, Doyle FJ 3rd, Cobelli C, Kovatchev BP: Modular closed-loop control of diabetes. IEEE Trans Biomed Eng 2012;59:2986-2999.
23. Zisser H, Palerm CC, Bevier WC, Doyle FJ 3rd, Jovanovic L: Clinical update on optimal prandial insulin dosing using a refined run-to-run control algorithm. J Diabetes Sci Technol 2009;3:487-491.
24. O'Grady MJ, Retterath AJ, Keenan DB, Kurtz N, Cantwell M, Spital G, Kremliovsky MN, Roy A, Davis EA, Jones TW, Ly TT: The use of an automated, portable glucose control system for overnight glucose control in adolescents and young adults with type 1 diabetes. Diabetes Care 2012;35:2182-2187.
25. Phillip M, Battelino T, Atlas E, Kordonouri O, Bratina N, Miller S, Biester T, Stefanija MA, Muller I, Nimri R, Danne T: Nocturnal glucose control with an artificial pancreas at a diabetes camp. N Engl J Med 2013;368:824-833.
26. Dauber A, Corcia L, Safer J, Agus MS, Einis S, Steil GM: Closed-loop insulin therapy improves glycemic control in children aged 27.Elleri D, Allen JM, Biagioni M, Kumareswaran K, Leelarathna L, Caldwell K, Nodale M, Wilinska ME, Acerini CL, Dunger DB, Hovorka R:Evaluation of a portable ambulatory prototype for automated overnight closed-loop insulin delivery in young people with type 1 diabetes.Pediatr Diabetes2012;13:449-453
27. Elleri D, Allen JM, Biagioni M, Kumareswaran K, Leelarathna L, Caldwell K, Nodale M, Wilinska ME, Acerini CL, Dunger DB, Hovorka R: Evaluation of a portable ambulatory prototype for automated overnight closed-loop insulin delivery in young people with type 1 diabetes. Pediatr Diabetes 2012;13:449-453.
28. Mauseth R, Hirsch IB, Bollyky J, Kircher R, Matheson D, Sanda S, Greenbaum C: Use of a "fuzzy logic" controller in a closed-loop artificial pancreas. Diabetes Technol Ther 2013;15:628-633.
29. Weinzimer SA, Sherr JL, Cengiz E, Kim G, Ruiz JL, Carria L, Voskanyan G, Roy A, Tamborlane WV: Effect of pramlintide on prandial glycemic excursions during closedloop control in adolescents and young adults with type 1 diabetes. Diabetes Care 2012;35:1994-1999.
30. Dalla Man C, Micheletto F, Lv D, Breton M, Kovatchev B, Cobelli C: The UVA/PADOVA type 1 diabetes simulator: new features. J Diabetes Sci Technol 2014;8:26-34.
31. Visentin R, Dalla Man C, Kovatchev B, Cobelli C: The University of Virginia/Padova type 1 diabetes simulator matches the glucose traces of a clinical trial. Diabetes Technol Ther 2014;16:428-434.
32. Soru P, De Nicolao G, Toffanin C, Dalla Man C, Cobelli C, Magni L; AP@home Consortium: MPC based artificial pancreas: strategies for individualization and meal compensation. Annu Rev Control 2012;36:118-128.
33. Toffanin C, Messori M, Di Palma F, De Nicolao G, Cobelli C, Magni L: Artificial pancreas: model predictive control design from clinical experience. J Diabetes Sci Technol 2013;7:1470-1483.
34. Del Favero S, Bruttomesso D, Di Palma F, Lanzola G, Visentin R, Filippi A, Scotton R, Toffanin C, Messori M, Scarpellini S, Keith-Hynes P, Kovatchev BP, Devries JH, Renard E, Magni L, Avogaro A, Cobelli C; AP@home Consortium: First use of model predictive control in outpatient wearable artificial pancreas. Diabetes Care 2014;37: 1212-1215.